chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-08 AccNo: 0001387131-17-003985 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-08-08 AccNo: 0001387131-17-003972 Size: 49 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-08 AccNo: 0001387131-17-003985 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2017-08-08 AccNo: 0001387131-17-003972 Size: 49 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 美东时间 2017-08-08 盘后 披露财报,预期EPS -0.25 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2017-05-12 AccNo: 0001387131-17-002694 Size: 43 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: ...
$OHR PHARMACEUTICAL INC(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-11 AccNo: 0001387131-17-002652 Size: 1 MB 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 8-K - Current report Filed: 2017-05-11 AccNo: 0001387131-17-002631 Size: 70 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ 美东时间 2017-05-11 盘后 披露财报,预期EPS -0.3 网页链接
$OHR PHARMACEUTICAL INC(OHRP)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2017-05-10 AccNo: 0001387131-17-002559 Size: 31 KB 网页链接